Alzheimer's drug gives researchers hope even as it raises more questions

An experimental drug slowed mental decline in Alzheimer's patients, but investors questioned its blockbuster potential. Doctors not involved with the study who reviewed the results said they were cautiously optimistic.

     

 

 

Read More